Jeremy Millar
Papers
5
Total Citations
565
H-Index
5
About
Jeremy Millar is a prominent clinical researcher specializing in prostate cancer outcomes, oncological quality metrics, and comparative treatment effectiveness. His work has made substantial contributions to understanding how different therapeutic approaches — including radical prostatectomy, radiotherapy, and robot-assisted surgery — affect survival and quality of life for men across the full spectrum of prostate cancer risk. Millar's most influential contribution, a 2012 comparative analysis through the Prostate Cancer Results Study Group, rigorously evaluated PSA-free survival outcomes across low, intermediate, and high-risk patients treated with radical therapies, accumulating an impressive 459 citations and establishing a benchmark for evidence-based treatment comparison. His subsequent research through the Victorian Prostate Cancer Registry has systematically examined surgical margin positivity, revealing the factors that contribute to positive margins and their downstream treatment implications. Notably, he has interrogated the rapidly growing adoption of robot-assisted radical prostatectomy, providing population-level evidence comparing its oncological and patient-reported outcomes against open surgery — work that directly informs clinical decision-making and patient counseling. Across his career, Millar has championed the use of clinical quality registries as powerful tools for generating real-world evidence, helping translate rigorous data collection into meaningful improvements in prostate cancer care at the population level.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5